Back to all studies
Active Not RecruitingNCT04464980

Optimizing Retention, Duration and Discontinuation Strategies for Addiction Pharmacotherapy (RDD)

This study is active but not recruiting. It focuses on addiction and currently lists study information in the United States.

Addiction, Addiction (OUD)BehavioralOver 18 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

This summary needs review. Please check the official study record and contact the research team for details.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)
  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: June 8, 2021
Recruitment status
Active Not Recruiting
Enrollment listed in the registry
1,516
Sponsor
NYU Langone Health
Sponsor type
Unknown or unclear
Study type
Behavioral
Intervention type
Psychotherapy / behavioral intervention, Medication / drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT04464980
Official title
NIDA-CTN-0100: Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT04464980. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

United States · 21 sites
  • University of Arkansas for Medical Sciences (UAMS) / Center for Addiction Services and Treatment (CAST)
    Little Rock, Arkansas
    Site status: Not listed — confirm with the team
  • Tarzana Treatment Centers, Inc.
    Tarzana, California
    Site status: Not listed — confirm with the team
  • Liberation Programs, Inc.
    Bridgeport, Connecticut
    Site status: Not listed — confirm with the team
  • Operation PAR
    Clearwater, Florida
    Site status: Not listed — confirm with the team
  • Gateway Community Services
    Jacksonville, Florida
    Site status: Not listed — confirm with the team
  • Aspire Health Partners
    Orlando, Florida
    Site status: Not listed — confirm with the team
  • Mountain Manor / Maryland Treatment Centers
    Baltimore, Maryland
    Site status: Not listed — confirm with the team
  • McLean Hospital
    Belmont, Massachusetts
    Site status: Not listed — confirm with the team
  • Stanley Street Treatment and Resources, Inc.
    Fall River, Massachusetts
    Site status: Not listed — confirm with the team
  • Square Medical Group, LLC
    Newton, Massachusetts
    Site status: Not listed — confirm with the team
  • Gibson Center for Behavioral Change
    Cape Girardeau, Missouri
    Site status: Not listed — confirm with the team
  • Dartmouth Hitchcock - ATP
    Lebanon, New Hampshire
    Site status: Not listed — confirm with the team
  • University of New Mexico Addiction and Substance Abuse Program
    Albuquerque, New Mexico
    Site status: Not listed — confirm with the team
  • Bellevue Hospital Center
    New York, New York
    Site status: Not listed — confirm with the team
  • Adapt Integrated Health Care
    Roseburg, Oregon
    Site status: Not listed — confirm with the team
  • Adapt Integrated Health Care
    Winston, Oregon
    Site status: Not listed — confirm with the team
  • Center for Psychiatric and Chemical Dependency Services (CPCDS)
    Pittsburgh, Pennsylvania
    Site status: Not listed — confirm with the team
  • Internal Medicine Recovery Engagement Program (IM-REP)
    Pittsburgh, Pennsylvania
    Site status: Not listed — confirm with the team
  • Shoreline Behavioral Health Services
    Conway, South Carolina
    Site status: Not listed — confirm with the team
  • Huntsman Mental Health Institute / University of Utah
    Salt Lake City, Utah
    Site status: Not listed — confirm with the team
  • Chestnut Ridge Center
    Morgantown, West Virginia
    Site status: Not listed — confirm with the team
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring psychotherapy or therapy for people with addiction. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

What is a behavioral study?

This appears to be a behavioral / psychological / psychosocial study involving SL-BUP, XR-BUP, XR-NTX, MM, MMR, MMD. Phase 2 studies usually explore whether the intervention may work, while continuing to monitor safety.

Are there criteria about substance use or wanting to reduce it?

The public registry appears to mention tobacco, nicotine, alcohol, cannabis, or another addiction-related topic. Ask the study team whether you need to want to stop, reduce, already be abstinent, or simply meet use-related criteria. Eligibility must be confirmed by the study team.

What would I likely need to do?

You may take part in sessions or exercises related to habits, thoughts, emotions, or behaviors. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

Will I need to change, stop, or stabilize my current treatment?

The public registry appears to mention rules about current treatment, stability, stopping treatment, or dose changes. Do not change your treatment for a study without medical guidance. Ask the study team and your clinician what is required, what is not allowed, and how safety is monitored.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by NYU Langone Health, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me